Gentian Diagnostics AS (GENT) — Cash Flow-to-Debt Ratio
Gentian Diagnostics AS (GENT) has a Cash Flow-to-Debt Ratio of 0.79x as of December 2025, meaning its operating cash flow of Nkr42.59 Million could theoretically repay 1% of its total liabilities (Nkr53.58 Million) in one year. See Gentian Diagnostics AS (GENT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gentian Diagnostics AS Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Gentian Diagnostics AS across 13 annual periods. Also explore GENT net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Gentian Diagnostics AS (2013–2025)
Year-by-year debt coverage analysis for Gentian Diagnostics AS. For market capitalisation and broader financial context, see GENT market cap.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | Nkr42.59 Million | Nkr53.58 Million | ▲ +110.4% |
| 2024 | 0.38x | Nkr13.46 Million | Nkr35.61 Million | ▼ -15.9% |
| 2023 | 0.45x | Nkr15.46 Million | Nkr34.40 Million | ▲ +208.3% |
| 2022 | -0.41x | Nkr-13.95 Million | Nkr33.62 Million | ▲ +43.2% |
| 2021 | -0.73x | Nkr-27.05 Million | Nkr37.02 Million | ▼ -288.1% |
| 2020 | -0.19x | Nkr-7.66 Million | Nkr40.69 Million | ▲ +83.4% |
| 2019 | -1.13x | Nkr-21.48 Million | Nkr18.94 Million | ▼ -26.0% |
| 2018 | -0.90x | Nkr-10.90 Million | Nkr12.11 Million | ▲ +57.7% |
| 2017 | -2.13x | Nkr-18.63 Million | Nkr8.75 Million | ▼ -99.8% |
| 2016 | -1.07x | Nkr-7.90 Million | Nkr7.42 Million | ▼ -12.7% |
| 2015 | -0.94x | Nkr-4.63 Million | Nkr4.90 Million | ▼ -475.3% |
| 2014 | -0.16x | Nkr-1.95 Million | Nkr11.88 Million | ▼ -184.7% |
| 2013 | 0.19x | Nkr2.43 Million | Nkr12.55 Million | — |